Skip to main content
. 2019 Apr 27;23(4):305–313. doi: 10.1007/s10151-019-01973-4

Table 2.

Patient outcomes of human cohort studies using ICG and MB. Only patients where visualization using fluorescence was attempted are included in the table

Article Reference Surgical specialism Laparoscopic/open Number of patients Administration Dose Ureters identified Complications
Indocyanine green Siddighi et al. (2014) [14] Gynaecologic Laparoscopic > 10 Ureteral catheter 25 mg in 10 mL/ureter All None
Lee et al. (2015) [15] Urologic Laparoscopic 25 Ureteral catheter and/or PNT 25 mg in 10 mL/ureter All Yes, in one patienta
Methylene blue Verbeek et al. (2013) [18] Abdominal Open 12 Intravenous 0.25–1 mg/kg 24/24 None
Yeung et al. (2016) [19] Colorectal Both 8 Intravenous 0.25–1 mg/kg 10/11 None
Al-Taher et al. (2016) [20] Colorectal Laparoscopic 9 Intravenous 0.125–1.0 mg/kg 6/9 None
Barnes et al. (2018) [21] Colorectal Both 40 Intravenous 0.25–1 mg/kg 63/69 None

NT percutaneous nephrostomy tube, ICG indocyanine green, MB methylene blue

aOrgan laceration due to trocar placement during uretero-ureterostomy